Stoke Therapeutics STOK
NASDAQ STOK
$25.88 +0.38 (+1.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Common Equity (2018 - 2026)

Updated

Stoke Therapeutics' Common Equity came in at $345.55 million for Q2 2026, up 3.2% from $334.94 million a year earlier but down 12.5% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Common Equity (2018 - 2026) Analysis & Trends

At the end of FY2025, Stoke Therapeutics' Common Equity was $352.46 million, up 53.9% from FY2024.

  • Common Equity carries a five-year compound annual growth rate of 4.3% (FY2020 to FY2025).
  • Going back by year, Common Equity was $229.02 million in FY2024 (+43.5%), $159.57 million in FY2023 (-13.7%), $184.85 million in FY2022 (-15.1%) and $217.78 million in FY2021 (-23.9%).
  • The five-year range for quarterly Common Equity is $140.34 million (Q1 2024) to $394.88 million (Q1 2026).
  • Year-over-year, Common Equity has increased for nine consecutive quarters, with growth averaging 46.0% over the last eight quarters.
  • The fastest year-over-year change in Common Equity over five years came in Q1 2025 (growth of 149.4%), and the weakest in Q1 2024 (a decline of 34.4%).
  • Business Quant data shows STOK's Common Equity at $394.88 million (Q1 2026), $352.46 million (Q4 2025) and $308.11 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Stoke Therapeutics 1.59 Bn 421.92 Mn - 345.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 345.55 Mn
Mar 31, 2026 394.88 Mn
Dec 31, 2025 352.46 Mn
Sep 30, 2025 308.11 Mn
Jun 30, 2025 334.94 Mn
Mar 31, 2025 350.07 Mn
Dec 31, 2024 229.02 Mn
Sep 30, 2024 232.11 Mn
Jun 30, 2024 242.71 Mn
Mar 31, 2024 140.34 Mn
Dec 31, 2023 159.57 Mn
Sep 30, 2023 173.00 Mn
Jun 30, 2023 190.20 Mn
Mar 31, 2023 213.82 Mn
Dec 31, 2022 184.85 Mn
Sep 30, 2022 204.14 Mn
Jun 30, 2022 224.32 Mn
Mar 31, 2022 239.98 Mn
Dec 31, 2021 217.78 Mn
Sep 30, 2021 237.51 Mn
API Access

Stoke Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=STOK&period=max&api_key=YOUR_API_KEY